Funding Organization: American Brain Tumor Association (ABTA)Grant Amount: Up to USD 200,000 (Two-Year Duration)Application Type: Multi-Institutional and Multi-Investigator Collaborative ResearchLetter of Intent (LOI) Deadline: December 10, 2025 Advancing Collaborative Brain Tumor Research The American Brain Tumor Association (ABTA) invites Letters of Intent (LOIs) for the 2026 Research Collaboration Grants, an initiative designed to accelerate discoveries in brain tumor research through team-based, interdisciplinary collaboration. This funding opportunity supports innovative, multi-institutional research projects that bring together diverse scientific perspectives to address the complexities of brain tumor biology, diagnosis, and treatment. By fostering collaboration between investigators across institutions and disciplines, the ABTA aims to drive scientific progress and improve outcomes for individuals and families affected by brain tumors. About the ABTA Research Program For more than five decades, the ABTA Research Program has been at the forefront of funding early-stage and breakthrough research in brain tumor science. The program supports both established and emerging researchers, encouraging innovative approaches that can lead to better understanding, diagnosis, and treatment of brain tumors. Through a variety of grant mechanisms including Discovery Grants, Basic Research Fellowships, and Research Collaboration Grants—the ABTA has built a global community of scientists dedicated to advancing the field and translating discoveries from the laboratory to clinical care. About the Research Collaboration Grant Purpose The Research Collaboration Grant is designed to promote team science and strengthen cross-institutional partnerships that can produce meaningful, measurable progress in brain tumor research. Each grant provides USD 200,000 over two years to support projects that unite researchers from multiple disciplines and institutions, fostering a comprehensive approach to understanding and treating brain tumors. This mechanism emphasizes synergy, innovation, and translational potential, supporting research that spans the continuum from basic discovery to clinical and population-level impact. Funding Overview Grant Value: Up to USD 200,000 total Duration: Two years (project-based funding) Project Type: Collaborative, multi-investigator, and multi-institutional research Objective: To promote team science and accelerate breakthroughs in brain tumor research Research Scope and Priorities Funded projects should integrate diverse methodologies and scientific approaches to explore the causes, effects, diagnosis, and treatment of brain tumors. Applications are encouraged to address one or more of the following domains: Basic Science: Molecular and cellular mechanisms underlying tumor initiation and progression. Translational Research: Development and validation of novel diagnostic tools, biomarkers, or therapeutic approaches. Clinical Research: Studies advancing early detection, precision medicine, or clinical outcomes. Epidemiological Research: Population-level studies that investigate incidence, risk factors, or disparities in brain tumor care and outcomes. Interdisciplinary approaches that connect these areas are strongly encouraged. Eligibility and Collaboration Requirements To promote collaboration and scientific integration, applicants must meet the following criteria: Co-Principal Investigators (Co-PIs): Each project must include at least two Co-PIs from different institutions. Both Co-PIs must play substantive roles in project design and implementation. Institutional Diversity: Collaborations may span academic, medical, or research institutions, including hospitals, universities, and non-profit research centers. Disciplinary Breadth: Teams should include investigators from complementary fields such as neuroscience, oncology, genetics, epidemiology, data science, or related disciplines. International Collaboration: Although the lead institution must be based in the United States, international collaborators are welcome to participate as co-investigators or partners. The ABTA encourages projects that integrate basic, translational, clinical, and epidemiological components, reflecting the multidimensional nature of brain tumor research. Application and Review Process Step 1: Letter of Intent (LOI) Interested applicants must submit a Letter of Intent (LOI) outlining their proposed research objectives, collaborative structure, and anticipated outcomes. Deadline: December 10, 2025 Format: Applicants should follow ABTA’s LOI submission guidelines available on the organization’s website. Purpose: The LOI allows the ABTA to assess project relevance, feasibility, and alignment with funding priorities. Shortlisted applicants will be invited to submit a full proposal following the LOI review stage. Step 2: Full Proposal (by invitation) Full applications will undergo a rigorous peer-review process, evaluating: Scientific quality and innovation. Relevance to ABTA’s mission. Feasibility and strength of the collaborative approach. Potential for translational or clinical impact. Final funding decisions will be based on scientific merit and the ability of the project to accelerate progress in brain tumor research. Key Dates LOI Submission Deadline: December 10, 2025 Invitation for Full Proposal: Early 2026 Grant Award Period: Two years, beginning mid-2026 Applicants are encouraged to review the ABTA’s official Research Collaboration Grant Guidelines for detailed submission requirements, eligibility, and review criteria. Why Apply? The ABTA Research Collaboration Grant provides a rare opportunity for scientists to: Engage in high-impact, team-based research that transcends disciplinary boundaries. Access significant funding to advance innovative ideas and cross-institutional partnerships. Contribute to global understanding of brain tumor biology and treatment. Build long-term collaborations that can extend beyond the grant period and lead to transformative outcomes in patient care. This funding mechanism reflects ABTA’s commitment to fostering collaboration, accelerating discovery, and improving the lives of people affected by brain tumors worldwide. How to Apply Researchers interested in applying should visit the ABTA Research Collaboration Grants page for complete details and submission instructions. Submit Letters of Intent by: December 10, 2025Funding Amount: Up to USD 200,000 over two yearsCollaborative Requirement: Minimum of two Co-PIs from different institutions About the American Brain Tumor Association Founded in 1973, the American Brain Tumor Association (ABTA) is the first national non-profit organization dedicated to brain tumor research, patient support, and education. The ABTA’s mission is to advance understanding and treatment of brain tumors through funding cutting-edge science, empowering patients, and advocating for change. LEARN MORE For more opportunities such as these please follow us on Facebook, Instagram , WhatsApp, Twitter, LinkedIn and Telegram Disclaimer: Global South Opportunities (GSO) is not the awarding organization. For any inquiries, please contact the official organization directly. Please do not send your applications to GSO, as we are unable to process them. Due to the high volume of emails, we receive daily, we may not be able to respond to all inquiries. Thank you for your understanding.